Engineering Microbes for Mucosal Drug Delivery

​

Tenza reprograms symbiotic bacteria from the human microbiome to administer medicines directly to the organs they naturally inhabit. We do so using a ML-powered, synthetic biology platform that enables us to engineer a wider diversity of bacteria to produce higher yields of drugs than ever before.

​

​

​

Tenza Team

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

 

​

 

 

Scientific Advisory Board

​

Rob Britton, Ph.D.

​

Wendy Garrett, M.D., Ph.D.

​

Steve Landau, M.D.

​

John March, Ph.D.

​

Todd Zion, Ph.D.

​

​

​

Contact

 

​

700 Main St., Cambridge, MA, USA

George Church, Ph.D.

Co-founder

Anik Debnath, Ph.D.

Co-founder & CEO

Todd Krueger

Board Director

Denise Sirias, Ph.D.

Principal Scientist

Ameet Shetty, Ph.D.

Principal Scientist 

Peter Lapchak, Ph.D.

Principal Scientist